Amphora® completed a phase III contraceptive clinical trial.

Read More


Amphora® offers potential applications for women all over the world.

Read More


Evofem is committed
to giving women access to better healthcare options.

Read More

Empower Women logo_vChange the World

Evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. Women need access to effective products that are well suited to their lifestyle and consistent with their core values.

Latest News


Evofem Biosciences Announces First Patient Enrolled in a Clinical Trial to Determine the Effect and Duration of Amphora Gel on Vaginal pH

August 17, 2016

SAN DIEGO, August 17, 2016 – Evofem Biosciences, a biotechnology company focused on the development and commercialization of women’s health products, has announced that patient enrollment has begun in their clinical study that will evaluate the effect and duration of Evofem Biosciences’ proprietary vaginal gel, Amphora for Bacterial Vaginosis (BV), on vaginal pH. BV is…

More News